RMACT’s IVF with PGS Opportunity Plan is the only all-inclusive IVF treatment plan that includes embryo screening.
When IVF is required for a patient to conceive, RMACT has the ability to screen each embryo for chromosomal abnormalities before the embryo is transferred back into the uterus. The purpose of Preimplantation Genetic Screening (PGS) is to identify and only transfer embryos that do not have abnormalities in their number of chromosomes. Screening embryos in advance can help achieve higher implantation rates and fewer pregnancy losses.
Patients who could benefit from PGS include: women 35 or older, those with multiple-failed IVF cycles and patients with recurrent miscarriages. This unique payment plan is available exclusively to RMACT patients who do not have insurance coverage for their fertility treatments.
To download both of RMACT's IVF pricing plans, please fill out the form on this page.